𝔖 Bobbio Scriptorium
✦   LIBER   ✦

8N Similar outcome in a randomized phase III trial comparing docetaxel versus vinorelbine both combined with trastuzumab as first line treatment for metastatic or locally advanced human epidermal growth factor receptor 2 (HER2) positive breast cancer

✍ Scribed by M. Andersson; E. Lidbrink; E. Wist; K. Enevoldsen; A.B. Jensen; P.G. Sørensen; K. Bjerre; S. Møller; J. Bergh; S.T. Langkjer


Book ID
119601021
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
43 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES